The proposed mechanism of IL-6/sIL-6Rα complex is to activate the various immune cells indicated via IL-6Rβ, which in combination would lead to potent anti-tumor effects (Th1 immune responses) [34]. The gene discussed is IL6; the disease is neoplasm.